ClassID:

94542

C07D241/28 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms in which said hetero-bound carbon atoms have double bonds to oxygen, sulfur or nitrogen atoms

Recent Application in this class:
#1
20250313550
2025-10-09

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

#2
20250223265
2025-07-10

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#3
20250122194
2025-04-17

NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS

#4
20250002463
2025-01-02

NEW SALT FORMS OF AMILORIDE AND ITS DERIVATIVES FOR PHARMACEUTICAL USE

#5
20240400541
2024-12-05

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

#6
20240294524
2024-09-05

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#7
20240254083
2024-08-01

HETEROCYCLIC TRPML1 AGONISTS AND USES THEREOF

#8
20240182430
2024-06-06

SYNTHESIS OF SUBSTITUTED PYRAZINES

#9
20230373922
2023-11-23

PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS FOR THE TREATMENT OF PANCREATIC CANCER

#10
20230192628
2023-06-22

MICROBIOCIDAL DERIVATIVES

#11
20230174467
2023-06-08

Compounds and methods of use

#12
20230167074
2023-06-01

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF, USE THEREOF, AND INTERMEDIATE THEREOF

#13
20230113598
2023-04-13

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#14
20230113085
2023-04-13

Small molecule inhibitors of TEAD transcription factors

#15
20230096380
2023-03-30

COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES AND NERVE DAMAGE, AND METHODS FOR PREPARING COMPOUNDS

#16
20230030414
2023-02-02

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

#17
20230002356
2023-01-05

COMPOUNDS AND USES THEREOF

#18
20220315538
2022-10-06

PURIFICATION OF SUBSTITUTED DIAMINOPYRAZINE DICARBOXYLIC ACIDS

#19
20220281830
2022-09-08

SALT

#20
20220213065
2022-07-07

Aminopyrazine diol compounds as PI3K-γ inhibitors

#21
20220153708
2022-05-19

TWO PIECE SENSOR ASSEMBLY AND METHOD OF USE

#22
20220127237
2022-04-28

FLUORESCENT PYRAZINE DERIVATIVES AND METHODS OF USING THE SAME IN ASSESSING RENAL FUNCTION

#23
20220002254
2022-01-06

ANODIC OXIDATION OF 5-AMINOURACIL

#24
20210261499
2021-08-26

Compounds and methods of use

#25
20210253558
2021-08-19

Inhibitors of prolyl-tRNA-synthetase

#26
20210228554
2021-07-29

Pyridine and pyrazine derivative for the treatment of chronic bronchitis

#27
20210114985
2021-04-22

Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds for the treatment of pancreatic cancer

#28
20210107881
2021-04-15

Anodic oxidation of 5-aminouracil

#29
20210070752
2021-03-11

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#30
20200339542
2020-10-29

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

#31
20200223805
2020-07-16

Two piece sensor assembly and method of use

#32
20200055825
2020-02-20

Compounds and methods for the targeted degradation of androgen receptor

#33
20200017438
2020-01-16

Compounds and methods of use

#34
20190330187
2019-10-31

Chemical compounds

#35
20190308943
2019-10-10

3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS

#36
20190276435
2019-09-12

Aminopyrazine diol compounds as PI3K-γ inhibitors

#37
20190262324
2019-08-29

Pyridine and Pyrazine Derivative for the Treatment of CF

#38
20190241528
2019-08-08

SODIUM CHANNEL BLOCKERS

#39
20190218190
2019-07-18

Substituted anilines for treatment of animal diseases

#40
20190194172
2019-06-27

PYRAZINE DERIVATIVES WITH EXTENDED CONJUGATION AND METHODS OF USING THE SAME IN OPTICAL APPLICATIONS

#41
20190119268
2019-04-25

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#42
20190084943
2019-03-21

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES WITH EPITHELIAL SODIUM CHANNEL BLOCKING ACTIVITY

#43
20190047995
2019-02-14

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#44
20190023709
2019-01-24

SHIP1 MODULATORS AND METHODS RELATED THERETO

#45
20180258073
2018-09-13

Pyrazines as modulators of GPR6

#46
20180201602
2018-07-19

Vicinal primary diamines associated with metal and/or free radical chelation motifs, and active against carbonyl and oxidative stress, and use thereof

#47
20180170922
2018-06-21

Substituted pyrazines as ATR kinase inhibitors

#48
20180162838
2018-06-14

Chemical compounds

#49
20180141921
2018-05-24

Therapeutic compounds

#50
20180065936
2018-03-08

Substituted anilines for treatment of animal diseases

#51
20170362187
2017-12-21

3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds

#52
20170327472
2017-11-16

Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity

#53
20170327469
2017-11-16

Compounds and methods for the targeted degradation of androgen receptor

#54
20170298030
2017-10-19

FLUORESCENT PYRAZINE DERIVATIVES AND METHODS OF USING THE SAME IN ASSESSING RENAL FUNCTION

#55
20170267650
2017-09-21

Sodium channel blockers

#56
20170174659
2017-06-22

Pyrazines as modulators of GPR6

#57
20170071919
2017-03-16

Pyridine and pyrazine derivative for the treatment of CF

#58
20170008859
2017-01-12

Therapeutic compounds

#59
20160331756
2016-11-17

Heterocyclic compounds useful as PDK1 inhibitors

#60
20160280666
2016-09-29

FLUORESCENT PYRAZINE DERIVATIVES AND METHODS OF USING THE SAME IN ASSESSING RENAL FUNCTION

#61
20160280665
2016-09-29

Fluorescent pyrazine derivatives and methods of using the same in assessing renal function

#62
20160159754
2016-06-09

Compounds for treatment of cystic fibrosis

#63
20160090376
2016-03-31

Pyrazine derivatives with extended conjugation and methods of using the same in optical applications

#64
20160030424
2016-02-04

Compounds useful as inhibitors of ATR kinase and combination therapies thereof

#65
20150376146
2015-12-31

SODIUM CHANNEL BLOCKERS

#66
20150376120
2015-12-31

Albicidin derivatives, their use and synthesis

#67
20150299142
2015-10-22

3,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxamide compounds

#68
20150051187
2015-02-19

Substituted pyrazines as ATR kinase inhibitors

#69
20150045364
2015-02-12

Pyridine and pyrazine derivative for the treatment of CF

#70
20150031661
2015-01-29

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#71
20150011535
2015-01-08

Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof

#72
20140371196
2014-12-18

Diamino heterocyclic carboxamide compound

#73
20140323463
2014-10-30

Pyrazinecarboxamide compound

#74
20140309209
2014-10-16

Pyrazine kinase inhibitors

#75
20140249135
2014-09-04

PIM KINASE INHIBITORS AND METHODS OF THEIR USE

#76
20140171447
2014-06-19

Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity

#77
20140170244
2014-06-19

3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds

#78
20140135329
2014-05-15

Pyridine and Pyrazine derivative for the Treatment of CF

#79
20140113005
2014-04-24

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

#80
20140044802
2014-02-13

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE AND COMBINATION THERAPIES THEREOF

#81
20140039191
2014-02-06

Fluorescent pyrazine derivatives and methods of using the same in assessing renal function

#82
20140039189
2014-02-06

Process for the preparation of acylguanidines and acylthioureas

#83
20130281464
2013-10-24

Biguanide derivative compound

#84
20130137660
2013-05-30

Pyridine derivatives useful as kinase inhibitors

#85
20130136698
2013-05-30

Integrated photoactive agents and uses thereof

#86
20130131040
2013-05-23

Substituted pyrazine-2-carboxamide kinase inhibitors

#87
20130109856
2013-05-02

NOVEL PROCESS FOR THE PREPARATION OF ACYLGUANIDINES AND ACYLTHIOUREAS

#88
20120208819
2012-08-16

Heterocyclic compounds useful as PDK1 inhibitors

#89
20120165343
2012-06-28

Glucagon receptor modulators

#90
20120149718
2012-06-14

Amido Compounds

#91
20120108611
2012-05-03

5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists

#92
20120040968
2012-02-16

Diamino heterocyclic carboxamide compound

#93
20120040020
2012-02-16

Compounds useful as inhibitors of ATR kinase

#94
20120027682
2012-02-02

Pyrazine derivatives for optical imaging and therapy

#95
20110059989
2011-03-10

3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases

#96
20100286171
2010-11-11

Substituted pyrazine compounds

#97
20100233091
2010-09-16

Pyrazine derivatives with extended conjugation and methods of using the same in optical applications

#98
20100222318
2010-09-02

Pyrazin-2-amines useful as inhibitors of ATR kinase

#99
20100196460
2010-08-05

Integrated photoactive agents for real-time monitoring of hemostasis

#100
20100130447
2010-05-27

Substituted pyrazines as inhibitors of kinase activity

#101
20100021382
2010-01-28

Pyrazine derivatives and uses thereof, including in medical imaging and visualization applications

#102
20100016304
2010-01-21

Glucokinase activator

#103
20100010223
2010-01-14

Pyrazine derivatives, Methods of use, and methods for preparing same

#104
20090318473
2009-12-24

5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists

#105
20090182140
2009-07-16

Alicyclic Heterocyclic Compound

#106
20090010851
2009-01-08

Fluorescent pyrazine derivatives and methods of using the same in assessing renal function

#107
20080119491
2008-05-22

AMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE